JP2018528262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528262A5 JP2018528262A5 JP2018526282A JP2018526282A JP2018528262A5 JP 2018528262 A5 JP2018528262 A5 JP 2018528262A5 JP 2018526282 A JP2018526282 A JP 2018526282A JP 2018526282 A JP2018526282 A JP 2018526282A JP 2018528262 A5 JP2018528262 A5 JP 2018528262A5
- Authority
- JP
- Japan
- Prior art keywords
- emollient
- oxide
- composition
- carbonate
- hydroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003974 emollient agent Substances 0.000 claims 29
- 239000000203 mixture Substances 0.000 claims 23
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims 14
- 239000011787 zinc oxide Substances 0.000 claims 13
- 235000014692 zinc oxide Nutrition 0.000 claims 13
- 229910052751 metal Inorganic materials 0.000 claims 12
- 239000002184 metal Substances 0.000 claims 12
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 11
- 239000004166 Lanolin Substances 0.000 claims 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 11
- 235000019388 lanolin Nutrition 0.000 claims 11
- 229940039717 lanolin Drugs 0.000 claims 11
- 229910052752 metalloid Inorganic materials 0.000 claims 11
- 150000002738 metalloids Chemical class 0.000 claims 11
- 229940105847 calamine Drugs 0.000 claims 6
- 239000010776 emu oil Substances 0.000 claims 6
- 229910052864 hemimorphite Inorganic materials 0.000 claims 6
- 229940119170 jojoba wax Drugs 0.000 claims 6
- 239000012188 paraffin wax Substances 0.000 claims 6
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 claims 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 4
- 241001135917 Vitellaria paradoxa Species 0.000 claims 4
- 235000013871 bee wax Nutrition 0.000 claims 4
- 239000012166 beeswax Substances 0.000 claims 4
- 229940092738 beeswax Drugs 0.000 claims 4
- 229940057910 shea butter Drugs 0.000 claims 4
- 229940044949 eucalyptus oil Drugs 0.000 claims 3
- 239000010642 eucalyptus oil Substances 0.000 claims 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- 208000010201 Exanthema Diseases 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims 2
- PPQREHKVAOVYBT-UHFFFAOYSA-H dialuminum;tricarbonate Chemical compound [Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O PPQREHKVAOVYBT-UHFFFAOYSA-H 0.000 claims 2
- 201000005884 exanthem Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 206010037844 rash Diseases 0.000 claims 2
- 239000004408 titanium dioxide Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- 239000011667 zinc carbonate Substances 0.000 claims 2
- 235000004416 zinc carbonate Nutrition 0.000 claims 2
- 229910000010 zinc carbonate Inorganic materials 0.000 claims 2
- FRWYFWZENXDZMU-UHFFFAOYSA-N 2-iodoquinoline Chemical compound C1=CC=CC2=NC(I)=CC=C21 FRWYFWZENXDZMU-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 206010011985 Decubitus ulcer Diseases 0.000 claims 1
- 206010012434 Dermatitis allergic Diseases 0.000 claims 1
- 206010012444 Dermatitis diaper Diseases 0.000 claims 1
- 208000003105 Diaper Rash Diseases 0.000 claims 1
- 206010013786 Dry skin Diseases 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 208000004210 Pressure Ulcer Diseases 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- 206010040880 Skin irritation Diseases 0.000 claims 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 229940118662 aluminum carbonate Drugs 0.000 claims 1
- 229910052788 barium Inorganic materials 0.000 claims 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 claims 1
- 229910052790 beryllium Inorganic materials 0.000 claims 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 claims 1
- LTPBRCUWZOMYOC-UHFFFAOYSA-N beryllium oxide Inorganic materials O=[Be] LTPBRCUWZOMYOC-UHFFFAOYSA-N 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims 1
- 239000000292 calcium oxide Substances 0.000 claims 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims 1
- 230000037336 dry skin Effects 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 239000011133 lead Substances 0.000 claims 1
- 229910000464 lead oxide Inorganic materials 0.000 claims 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 1
- 239000001095 magnesium carbonate Substances 0.000 claims 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 1
- 239000000395 magnesium oxide Substances 0.000 claims 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical group O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical class CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001185 psoriatic effect Effects 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 231100000475 skin irritation Toxicity 0.000 claims 1
- 230000036556 skin irritation Effects 0.000 claims 1
- 239000011135 tin Substances 0.000 claims 1
- 229910052718 tin Inorganic materials 0.000 claims 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims 1
- 229910001887 tin oxide Inorganic materials 0.000 claims 1
- 229910052719 titanium Inorganic materials 0.000 claims 1
- 239000010936 titanium Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903098 | 2015-08-04 | ||
| AU2015903098A AU2015903098A0 (en) | 2015-08-04 | Emollient composition | |
| PCT/AU2016/050704 WO2017020087A1 (en) | 2015-08-04 | 2016-08-04 | Emollient composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018528262A JP2018528262A (ja) | 2018-09-27 |
| JP2018528262A5 true JP2018528262A5 (cg-RX-API-DMAC7.html) | 2019-09-05 |
| JP6856642B2 JP6856642B2 (ja) | 2021-04-07 |
Family
ID=57942176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018526282A Active JP6856642B2 (ja) | 2015-08-04 | 2016-08-04 | 皮膚軟化組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10596102B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3313369B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6856642B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108024946A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016302401B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2994177C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3313369T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2824477T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ739505A (cg-RX-API-DMAC7.html) |
| PL (1) | PL3313369T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017020087A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107041854A (zh) * | 2017-05-27 | 2017-08-15 | 许昌学院 | 一种假发处理工人专用裂手霜及其制备方法 |
| WO2024091162A1 (en) * | 2022-10-25 | 2024-05-02 | Aak Ab (Publ) | Uv filter composition comprising triterpenes, emollients and inorganic uv-filters |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020012648A1 (en) * | 1998-02-06 | 2002-01-31 | Orthoefer Frank T. | High phospholipid-containing dermatological compositions |
| GB0027674D0 (en) * | 2000-11-13 | 2000-12-27 | Johnson & Johnson Medical Ltd | Hydrogel wound dressings |
| SE0201566D0 (sv) * | 2002-05-27 | 2002-05-27 | Karlshamns Ab | New composition |
| US6911196B2 (en) * | 2002-07-31 | 2005-06-28 | Samir I. Hamtini | Topical medicament for treating nappy rash |
| JP2005132753A (ja) * | 2003-10-29 | 2005-05-26 | Hideo Ogiwara | 外皮用医薬組成物 |
| US20080107751A1 (en) * | 2004-03-10 | 2008-05-08 | Jeff Hudnall | Antimicrobial Wax Composition for Wax Therapy |
| US20090011042A1 (en) * | 2005-07-26 | 2009-01-08 | Global Life Technologies, Corp | Antimicrobial and antiviral composition |
| US20080286390A1 (en) | 2007-05-16 | 2008-11-20 | Judy Tanyi | Skin care composition |
| US8623335B2 (en) * | 2007-09-10 | 2014-01-07 | Tauna Ann Waddington | Scar and rosacea and other skin care treatment composition and method |
| WO2010018418A1 (en) * | 2008-08-12 | 2010-02-18 | Novatech D.O.O. | Formulation based on micronized clinoptilolite as therapeutic agent providing highly bioavailable silicon |
| US8846063B2 (en) * | 2008-12-16 | 2014-09-30 | Kimberly-Clark Worldwide, Inc. | Personal care composition containing a volatile and a terpene alcohol |
| US8551517B2 (en) * | 2008-12-16 | 2013-10-08 | Kimberly-Clark Worldwide, Inc. | Substrates providing multiple releases of active agents |
| US8673328B2 (en) * | 2010-04-11 | 2014-03-18 | Agnes Mwangi Blomberg | Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water |
| EP2804606B1 (en) * | 2012-01-19 | 2017-06-28 | Hybrid Medical, LLC | Topical therapeutic formulations |
| CA2896646A1 (en) * | 2012-12-27 | 2014-07-03 | Hayashibara Co., Ltd. | Skin-exterior anti-ageing composition and production method therefor |
| SMT201900709T1 (it) * | 2014-08-20 | 2020-01-14 | Samumed Llc | Gamma-dichetoni per trattamento e prevenzione di pelle in invecchiamento e rughe |
| CN104800430A (zh) * | 2015-05-23 | 2015-07-29 | 唐赢 | 一种改善睡眠深度的精油 |
-
2016
- 2016-08-04 NZ NZ739505A patent/NZ739505A/en unknown
- 2016-08-04 AU AU2016302401A patent/AU2016302401B2/en active Active
- 2016-08-04 WO PCT/AU2016/050704 patent/WO2017020087A1/en not_active Ceased
- 2016-08-04 PL PL16831981T patent/PL3313369T3/pl unknown
- 2016-08-04 CN CN201680054313.2A patent/CN108024946A/zh active Pending
- 2016-08-04 EP EP16831981.2A patent/EP3313369B1/en active Active
- 2016-08-04 US US15/749,299 patent/US10596102B2/en active Active
- 2016-08-04 CA CA2994177A patent/CA2994177C/en active Active
- 2016-08-04 ES ES16831981T patent/ES2824477T3/es active Active
- 2016-08-04 DK DK16831981.2T patent/DK3313369T3/da active
- 2016-08-04 JP JP2018526282A patent/JP6856642B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508936A5 (cg-RX-API-DMAC7.html) | ||
| JP2016532722A5 (cg-RX-API-DMAC7.html) | ||
| WO2017025936A3 (en) | Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne | |
| JP2017105763A5 (cg-RX-API-DMAC7.html) | ||
| EA201401031A1 (ru) | Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей | |
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| WO2014186742A3 (en) | Anhydrous hydrogel composition | |
| WO2019035705A3 (es) | Composición tópica semisólida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños crónicos de la piel | |
| JP2014505733A5 (cg-RX-API-DMAC7.html) | ||
| WO2016137164A3 (ko) | 바실러스 속 세균 유래 세포밖 소포체를 포함하는 임신관련 질환 치료용 조성물 | |
| EP4552650A3 (en) | Methods and compositions for treatment of skin | |
| WO2016020861A3 (pt) | Composição vaginal para tratamento de infeções urogenitais | |
| JP2016514121A5 (cg-RX-API-DMAC7.html) | ||
| WO2016142708A3 (en) | Pharmaceutical composition | |
| JP2018529666A5 (cg-RX-API-DMAC7.html) | ||
| JP2018528262A5 (cg-RX-API-DMAC7.html) | ||
| WO2023275413A3 (en) | Solid pharmaceutical formulations of varenicline | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| JP2017001966A5 (cg-RX-API-DMAC7.html) | ||
| EP3873480B1 (en) | Anti-acne composition | |
| JP2020525452A5 (cg-RX-API-DMAC7.html) | ||
| JP2018162320A5 (cg-RX-API-DMAC7.html) | ||
| MX2023010872A (es) | Nueva composición tópica libre de tensioactivos derivados de sulfato. | |
| JP2017503864A5 (cg-RX-API-DMAC7.html) |